Impacts of the EU sugar policy reforms on developing countries

This report analyses the impacts of the Commission's July 2004 proposal for sugar policy reforms on developing countries. The study uses three approaches that complement each other: model simulations, literature review and country case studies. Model simulations indicate that the consequences of the EU policy reform on EU imports are rather modest: imports from LDCs increase but to a lesser extent than the Commission and other studies indicate. Important trigger points in the evaluation of the impact on trade flows are the degree of substitutability between domestic EU sugar and imported sugar, and potential 'swap' or trade diversion effects. Welfare effects are minor to ACP countries as a group, but country effects may differ strongly. The study includes three case studies - Ethiopia, Mauritius and Brazil, representing an EBA, an ACP and a net exporting country with no preferences to the EU market - to show how EU policy changes may affect the sugar industry in each of these countries.Agricultural and Food Policy,

Measurement of bone mineral mass in clinical perspective

It has now became possible to measure the bone mineral content in the axial as well as the peripheral skeleton. Moreover, with the use of computed tomography a selective assessment can be made of cancellous (trabecular) versus cortical bone mineral density. These technical achievements have led to a better understanding of the pathophysiology of osteoporosis and provided information on the effects of therapeutic interventions. Despite these sophisticated methods for bone mineral assessment the diagnosis of osteoporosis remains based on the occurrence of non-traumatic fractures and for that purpose an ordinary X-ray will be sufficient. For investigational use several non-invasive methods for measuring bone mineral mass have been developed, although only photonabsorptiometry (Single and Dual energy: SPA and DPA. respectively) and Quantitative Computed Tomography (QCT) are operational in large scale clinical practice. The advantages of photonabsorptiometry and the more recently developed Dual Energy Xray Absorptiometry (DEXA) over QCT are the lower radiation exposure, lower costs, better accuracy and precision and easier operation. The great advantage of QCT is the unique possibility to measure cancellous and cortical bone separately. With these non-invasive methods of bone mineral assessment is has been shown that women will lose during their lifes about 35 percent of their cortical and about 50 percent of their cancellous bone. We studied this pattern of age-related bone loss cross-sectionally in 171 healthy Dutch women and observed an accelerated bone loss around the menopause at all measurement sites (see Chapter 5). Further analyses showed that the onset of cortical bone loss as measured by SPA occurs on the average at least a decade later than the onset of cancellous bone loss which already manifests itself before the menopause. This pattern of cancellous and cortical bone loss during aging shows a parrallelism with the observed patterns of incidence of age-related fractures. The incidence of Colles fractures in women rises soon after the menopause and a plateau is reached around the age of 65. This type of fracture (distal forearm) occurs at a site containing a relatively high proportion of cancellous bone. On the other hand, the incidence of hip fractures increases slowly with age, which rise accelerates late in life in both men and women. This type of fracture characteristically is one of cortical bone. Somewhere between these two types of fractures the vertebral compression fractures take position. They occur soon after the menopause and the incidence apppears to rise over the two decades after menopause. The vertebral body contains about equal amounts of cancellous and cortical bone

Figuring out what they feel : Exposure to eudaimonic narrative fiction is related to mentalizing ability

Being exposed to narrative fiction may provide us with practice in dealing with social interactions and thereby enhance our ability to engage in mentalizing (understanding other people’s mental states). The current study uses a confirmatory Bayesian approach to assess the relationship between mentalizing and both the self-reported frequency of exposure to narrative fiction across media (books, films, and TV series) and the particular types of fiction that are consumed (eudaimonic vs. hedonic). This study focuses on this relationship in children and adolescents, because they are still developing their social abilities. Exposure to narrative fiction may thus be particularly important in providing input on how to interpret other people’s mental states for this age group. In our study, we find no evidence for a simple relationship between overall frequency of narrative fiction exposure and mentalizing ability in this age group. However, exposure to eudaimonic narrative fiction is consistently positively related to mentalizing and, for some media types and aspects of mentalizing, more strongly so than exposure to hedonic narrative fiction. No evidence was obtained to suggest that there are any differential effects related to the medium of the narrative fiction exposure (written vs. visual).acceptedVersio

The ERP response to the amount of information conveyed by words in sentences

Contains fulltext : 132194.pdf (publisher's version ) (Open Access)Reading times on words in a sentence depend on the amount of information the words convey, which can be estimated by probabilistic language models. We investigate whether event-related potentials (ERPs), too, are predicted by information measures. Three types of language models estimated four different information measures on each word of a sample of English sentences. Six different ERP deflections were extracted from the EEG signal of participants reading the same sentences. A comparison between the information measures and ERPs revealed a reliable correlation between N400 amplitude and word surprisal. Language models that make no use of syntactic structure fitted the data better than did a phrase-structure grammar, which did not account for unique variance in N400 amplitude. These findings suggest that different information measures quantify cognitively different processes and that readers do not make use of a sentence’s hierarchical structure for generating expectations about the upcoming word.11 p

Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial

Preference for a drug formulation is important in adherence to long-term medication for chronic illnesses such as osteoporosis. We investigated the preference for and acceptability of chewable tablet containing calcium and vitamin D (Calci Chew D3, Nycomed) compared to that of a sachet containing calcium and vitamin D3 (Cad, Will-Pharma). This open, randomised, cross-over trial was set up to compare the preference and acceptability of two calcium plus vitamin D3 formulations (both with 500 mg calcium and 400/440 IU vitamin D3), given twice a day in patients with osteoporosis. Preference and acceptability were assessed by means of questionnaires. Preference was determined by asking the question, which treatment the patient preferred, and acceptability was measured by scoring five variables, using rating scales. Of the 102 patients indicating a preference for a trial medication, 67% preferred the chewable tablet, 19% the sachet with calcium and vitamin D3, and 15% stated no preference. The significant preference for Calci Chew D3 (p < 0.0001) was associated with higher scores for all five acceptability variables. The two formulations were tolerated equally well. A significant greater number of patients considered the chewable tablet as preferable and acceptable to the sachet, containing calcium and vitamin D3. Trial registration: Current Controlled Trials ISRCTN18822358

A neurocomputational model of the N400 and the P600 in semantic processing.

Ten years ago, researchers using event-related brain potentials (ERPs) to study language comprehension were puzzled by what looked like a Semantic Illusion: Semantically anomalous, but structurally well-formed sentences did not affect the N400 component—traditionally taken to reflect semantic integration—but instead produced a P600 effect, which is generally linked to syntactic processing. This finding led to a considerable amount of debate, and a number of complex processing models have been proposed as an explanation. What these models have in common is that they postulate two or more separate processing streams, in order to reconcile the Semantic Illusion and other semantically induced P600 effects with the traditional interpretations of the N400 and the P600. Recently, however, these multi-stream models have been called into question, and a simpler single-stream model has been proposed. According to this alternative model, the N400 component reflects the retrieval of word meaning from semantic memory, and the P600 component indexes the integration of this meaning into the unfolding utterance interpretation. In the present paper, we provide support for this “Retrieval–Integration (RI)” account by instantiating it as a neurocomputational model. This neurocomputational model is the first to successfully simulate the N400 and P600 amplitude in language comprehension, and simulations with this model provide a proof of concept of the single-stream RI account of semantically induced patterns of N400 and P600 modulations

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Background: Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In the 3-year assessment of the SCALE Obesity and Prediabetes trial we aimed to evaluate the proportion of individuals with prediabetes who were diagnosed with type 2 diabetes. Methods: In this randomised, double-blind, placebo-controlled trial, adults with prediabetes and a body-mass index of at least 30 kg/m2, or at least 27 kg/m2 with comorbidities, were randomised 2:1, using a telephone or web-based system, to once-daily subcutaneous liraglutide 3·0 mg or matched placebo, as an adjunct to a reduced-calorie diet and increased physical activity. Time to diabetes onset by 160 weeks was the primary outcome, evaluated in all randomised treated individuals with at least one post-baseline assessment. The trial was conducted at 191 clinical research sites in 27 countries and is registered with ClinicalTrials.gov, number NCT01272219. Findings: The study ran between June 1, 2011, and March 2, 2015. We randomly assigned 2254 patients to receive liraglutide (n=1505) or placebo (n=749). 1128 (50%) participants completed the study up to week 160, after withdrawal of 714 (47%) participants in the liraglutide group and 412 (55%) participants in the placebo group. By week 160, 26 (2%) of 1472 individuals in the liraglutide group versus 46 (6%) of 738 in the placebo group were diagnosed with diabetes while on treatment. The mean time from randomisation to diagnosis was 99 (SD 47) weeks for the 26 individuals in the liraglutide group versus 87 (47) weeks for the 46 individuals in the placebo group. Taking the different diagnosis frequencies between the treatment groups into account, the time to onset of diabetes over 160 weeks among all randomised individuals was 2·7 times longer with liraglutide than with placebo (95% CI 1·9 to 3·9, p&lt;0·0001), corresponding with a hazard ratio of 0·21 (95% CI 0·13–0·34). Liraglutide induced greater weight loss than placebo at week 160 (–6·1 [SD 7·3] vs −1·9% [6·3]; estimated treatment difference −4·3%, 95% CI −4·9 to −3·7, p&lt;0·0001). Serious adverse events were reported by 227 (15%) of 1501 randomised treated individuals in the liraglutide group versus 96 (13%) of 747 individuals in the placebo group. Interpretation: In this trial, we provide results for 3 years of treatment, with the limitation that withdrawn individuals were not followed up after discontinuation. Liraglutide 3·0 mg might provide health benefits in terms of reduced risk of diabetes in individuals with obesity and prediabetes. Funding: Novo Nordisk, Denmark

A randomized, controlled trial of 3.0 mg of liraglutide in weight management

BACKGROUND Obesity is a chronic disease with serious health consequences, but weight loss is difficult to maintain through lifestyle intervention alone. Liraglutide, a glucagonlike peptide-1 analogue, has been shown to have potential benefit for weight management at a once-daily dose of 3.0 mg, injected subcutaneously. METHODS We conducted a 56-week, double-blind trial involving 3731 patients who did not have type 2 diabetes and who had a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of at least 30 or a BMI of at least 27 if they had treated or untreated dyslipidemia or hypertension. We randomly assigned patients in a 2:1 ratio to receive once-daily subcutaneous injections of liraglutide at a dose of 3.0 mg (2487 patients) or placebo (1244 patients); both groups received counseling on lifestyle modification. The coprimary end points were the change in body weight and the proportions of patients losing at least 5% and more than 10% of their initial body weight. RESULTS At baseline, the mean (±SD) age of the patients was 45.1±12.0 years, the mean weight was 106.2±21.4 kg, and the mean BMI was 38.3±6.4; a total of 78.5% of the patients were women and 61.2% had prediabetes. At week 56, patients in the liraglutide group had lost a mean of 8.4±7.3 kg of body weight, and those in the placebo group had lost a mean of 2.8±6.5 kg (a difference of -5.6 kg; 95% confidence interval, -6.0 to -5.1; P&lt;0.001, with last-observation-carried-forward imputation). A total of 63.2% of the patients in the liraglutide group as compared with 27.1% in the placebo group lost at least 5% of their body weight (P&lt;0.001), and 33.1% and 10.6%, respectively, lost more than 10% of their body weight (P&lt;0.001). The most frequently reported adverse events with liraglutide were mild or moderate nausea and diarrhea. Serious events occurred in 6.2% of the patients in the liraglutide group and in 5.0% of the patients in the placebo group. CONCLUSIONS In this study, 3.0 mg of liraglutide, as an adjunct to diet and exercise, was associated with reduced body weight and improved metabolic control. (Funded by Novo Nordisk; SCALE Obesity and Prediabetes NN8022-1839 ClinicalTrials.gov number, NCT01272219.)

Genetics of Dispersal

Dispersal is a process of central importance for the ecological and evolutionary dynamics of populations and communities, because of its diverse consequences for gene flow and demography. It is subject to evolutionary change, which begs the question, what is the genetic basis of this potentially complex trait? To address this question, we (i) review the empirical literature on the genetic basis of dispersal, (ii) explore how theoretical investigations of the evolution of dispersal have represented the genetics of dispersal, and (iii) discuss how the genetic basis of dispersal influences theoretical predictions of the evolution of dispersal and potential consequences. Dispersal has a detectable genetic basis in many organisms, from bacteria to plants and animals. Generally, there is evidence for significant genetic variation for dispersal or dispersal-related phenotypes or evidence for the micro-evolution of dispersal in natural populations. Dispersal is typically the outcome of several interacting traits, and this complexity is reflected in its genetic architecture: while some genes of moderate to large effect can influence certain aspects of dispersal, dispersal traits are typically polygenic. Correlations among dispersal traits as well as between dispersal traits and other traits under selection are common, and the genetic basis of dispersal can be highly environment-dependent. By contrast, models have historically considered a highly simplified genetic architecture of dispersal. It is only recently that models have started to consider multiple loci influencing dispersal, as well as non-additive effects such as dominance and epistasis, showing that the genetic basis of dispersal can influence evolutionary rates and outcomes, especially under non-equilibrium conditions. For example, the number of loci controlling dispersal can influence projected rates of dispersal evolution during range shifts and corresponding demographic impacts. Incorporating more realism in the genetic architecture of dispersal is thus necessary to enable models to move beyond the purely theoretical towards making more useful predictions of evolutionary and ecological dynamics under current and future environmental conditions. To inform these advances, empirical studies need to answer outstanding questions concerning whether specific genes underlie dispersal variation, the genetic architecture of context-dependent dispersal phenotypes and behaviours, and correlations among dispersal and other traits.Peer reviewe